Search Results 1461-1470 of 16786 for Bioavailability
Lester PR, Murawska Baptista A, Tapia Stoll N, Skinner P, Singla A. Septic Arthritis Secondary to Acupuncture in an Immunocompromised Patient With Multiple ...
Biotherapeutic medicines focus on rebuilding health while treating symptoms of disease. It's an emerging area of medicine aimed at stopping disease on a ...
Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to the early treatment of these complex injuries.
Janssens L, Ji H, Greenlund A. Porphyria Cutanea Tarda. Clin Gastroenterol Hepatol. 2021 Sep; 19 (9):A19 Epub 2020 May 21
ROCHESTER, Minn. — Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns ...
About this study. The purpose of this study is to estimate the real-world Objective Response Rate (rwORR) to standard therapy in subjects with locally ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Publications · Radosevich M, Anderson A, Teixeira M, Diwan T, Heimbach J, Taner T, Spencer P, Diaz Soto J, Reynolds A, Neff A, Krowka M, Bohman J. · Ripoll JG, ...
Peter A. Noseworthy, M.D., M.B.A. · Cardiac Electrophysiologist · Cardiologist.
About this study. This project aims to understand the risk factors for neonatal late-onset sepsis (LOS), a leading cause of death of preterm newborns.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.